Cognitive performance during the first year of treatment in first-episode schizophrenia: a case–control study

Cognitive Performance of Individuals With Schizophrenia Across Seven Decades: A Study Using the MATRICS Consensus Cognitive Battery

(2013) Tarek K. Rajji et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Cognitive remediation as a treatment for major depression: A rationale, review of evidence and recommendations for future research

(2013) Richard J Porter et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis

(2013) G. Désaméricq et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis

(2013) Kristen A. Woodberry et al.   SCHIZOPHRENIA RESEARCH

Neurocognitive development in first episode psychosis 5years follow-up: Associations between illness severity and cognitive course

(2013) Helene Eidsmo Barder et al.   SCHIZOPHRENIA RESEARCH

Schizophrenia Is a Cognitive Illness

(2013) René S. Kahn et al.   JAMA Psychiatry

Neurocognitive function in long-term treated schizophrenia: A five-year follow-up study

(2012) Maria Ekerholm et al.   PSYCHIATRY RESEARCH

Longitudinal Studies of Cognition in First Episode Psychosis: A Systematic Review of the Literature

(2011) Vasilis P. Bozikas et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Neurocognitive Predictors of Work Outcome in Recent-Onset Schizophrenia

(2011) K. H. Nuechterlein et al.   SCHIZOPHRENIA BULLETIN

Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?

(2011) Richard S. E. Keefe et al.   SCHIZOPHRENIA BULLETIN

Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies

(2010) Terry E Goldberg et al.   NEUROPSYCHOPHARMACOLOGY

The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?

(2010) R. W. Buchanan et al.   SCHIZOPHRENIA BULLETIN

Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

(2009) Michael Davidson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Schizophrenia, “just the facts” 4. Clinical features and conceptualization

(2009) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity

(2008) Keith H. Nuechterlein et al.   AMERICAN JOURNAL OF PSYCHIATRY

General and Specific Cognitive Deficits in Schizophrenia: Goliath Defeats David?

(2008) Dwight Dickinson et al.   BIOLOGICAL PSYCHIATRY

Predicting Schizophrenia Patients’ Real-World Behavior with Specific Neuropsychological and Functional Capacity Measures

(2007) Christopher R. Bowie et al.   BIOLOGICAL PSYCHIATRY